InvestorsHub Logo
Followers 62
Posts 7498
Boards Moderated 1
Alias Born 01/02/2003

Re: oneragman post# 114705

Sunday, 09/24/2017 6:11:34 AM

Sunday, September 24, 2017 6:11:34 AM

Post# of 423968
HDG:......."In Dec. 2016, the US Supreme Court ruled in Apple vs Samsung, that a patent violator did not have to turn over all the profits from sales of a product using stolen designs when the designs covered only certain things and not the whole thing. (The ruling was about design and not utility).

So is it possible that AZN can be sued by AMRN for taking E to market because it violates AMRN patents. Yes. Can AMRN keep E off the market? Maybe. Since E would only be violating some, but not all patents, could the Apple ruling be applied?"..............

Amarin's over 50 patents protect not only ingredient composition, but also manufacturing techniques and usage. The Apple vs. Samsuhg case was only about patents on parts. IMO Amarin's case is very strong against E and against generics.....That is not to say that, with so much money at stake, infringers will try against long odds at some point in time to bust these patents......Perhaps the most important and prescient move that Amarin made these past years was to continue to develop their patent portfolio.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News